236 related articles for article (PubMed ID: 18228100)
1. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
Leung E; McArthur D; Morris A; Williams N
Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
[TBL] [Abstract][Full Text] [Related]
2. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.
Onoda T; Ono T; Dhar DK; Yamanoi A; Fujii T; Nagasue N
J Lab Clin Med; 2004 Apr; 143(4):207-16. PubMed ID: 15085079
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.
Yazawa K; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Asakage M; Sunami E; Kaisaki S; Hori N; Watanabe T; Takahashi K; Nagawa H
Cancer Sci; 2005 Feb; 96(2):93-9. PubMed ID: 15723653
[TBL] [Abstract][Full Text] [Related]
5. Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
Li WZ; Huo QJ; Wang XY; Xu F
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):113-9. PubMed ID: 20709621
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
[TBL] [Abstract][Full Text] [Related]
7. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression correlates with membrane-type-1 matrix metalloproteinase expression in colorectal cancer tissue.
Guo H; Tatsuguchi A; Shinji S; Fujimori S; Tanaka S; Gudis K; Sugisaki Y; Furukawa K; Tajiri T; Fukuda Y; Kishida T; Sakamoto C
Dis Colon Rectum; 2006 Aug; 49(8):1184-92. PubMed ID: 16752205
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of cyclooxygenase-2 inhibitor in inhibition of proliferation of colon cancer cells by modulating Stat5 signal transduction pathway].
Ma XT; Yu LW; Wang S; Zhang H; Du RY; Cui ZR
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2566-9. PubMed ID: 16321305
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines.
Parker J; Kaplon MK; Alvarez CJ; Krishnaswamy G
Exp Cell Res; 1997 Oct; 236(1):321-9. PubMed ID: 9344613
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines.
Lev-Ari S; Maimon Y; Strier L; Kazanov D; Arber N
J Soc Integr Oncol; 2006; 4(1):21-6. PubMed ID: 16737669
[TBL] [Abstract][Full Text] [Related]
14. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells.
Lee EJ; Choi EM; Kim SR; Park JH; Kim H; Ha KS; Kim YM; Kim SS; Choe M; Kim JI; Han JA
Exp Mol Med; 2007 Aug; 39(4):469-76. PubMed ID: 17934334
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide promoted proliferation and invasion of endometriotic stromal cells via induction of cyclooxygenase-2 expression.
Takenaka Y; Taniguchi F; Miyakoda H; Takai E; Terakawa N; Harada T
Fertil Steril; 2010 Jan; 93(1):325-7. PubMed ID: 19647233
[TBL] [Abstract][Full Text] [Related]
20. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
